Literature DB >> 666949

Compliance with anticonvulsant therapy in a hospital clinic and in the community.

J C Mucklow, C T Dollery.   

Abstract

1 Seizure control, saliva anticonvulsant concentration, prescribing habits and compliance with anticonvulsant medication have been compared in 86 epileptic subjects attending either a specialist hospital clinic or general practice surgeries. 2 Of all subjects experiencing recurrent seizures 70% had saliva concentrations of phenytoin below the range equivalent to the 'therapeutic range' of plasma concentration. Mean saliva phenytoin concentrations did not differ significantly between the two treatment settings and were low largely because of the low mean dosage prescribed. 3 Eleven subjects in all had no detectable phenytoin in their and could clearly be identified as noncompliant. Freedom from seizures appeared to predispose to poor compliance in these subjects as well as among those admitting repeated omission of doses.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666949      PMCID: PMC1429385          DOI: 10.1111/j.1365-2125.1978.tb01685.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Homogenous immunochemical drug assays.

Authors:  R J Bastiani; R C Phillips; R S Schneider; E F Ullman
Journal:  Am J Med Technol       Date:  1973-06

2.  Plasma diphenylhydantoin levels in Australian adults.

Authors:  W D Hooper; J H Tyrer; M J Eadie
Journal:  Aust N Z J Med       Date:  1974-10

3.  Diphenylhydantoin concentrations in saliva.

Authors:  F Bochner; W D Hooper; J M Sutherland; M J Eadie; J H Tyrer
Journal:  Arch Neurol       Date:  1974-07

4.  Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital.

Authors:  F Vajda; F M Williams; S Davidson; M A Falconer; A Breckenridge
Journal:  Clin Pharmacol Ther       Date:  1974-06       Impact factor: 6.875

5.  Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography.

Authors:  J MacGee
Journal:  Anal Chem       Date:  1970-03       Impact factor: 6.986

6.  How doctors deal with epilepsy.

Authors:  A Hopkins; G Scambler
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

7.  Some causes of ineffectiveness of diphenylhydantoin.

Authors:  H Kutt; J Haynes; F McDowell
Journal:  Arch Neurol       Date:  1966-05

8.  Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.

Authors:  C E Cook; E Amerson; W K Poole; P Lesser; L O'Tuama
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

9.  Control of epilepsy with a single daily dose of phenytoin sodium.

Authors:  D A Cocks; E M Critchley
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

10.  Supervision of epileptic patients taking phenytoin.

Authors:  F B Gibberd; J F Dunne; A J Handley; B L Hazleman
Journal:  Br Med J       Date:  1970-01-17
View more
  1 in total

Review 1.  Therapeutic drug monitoring of anticonvulsants. State of the art.

Authors:  I A Choonara; A Rane
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.